Significance of Chest Computed Tomography in the Clinical Outcome of Patients with Low-Risk Gestational Trophoblastic Neoplasia

被引:0
|
作者
De Ramos, Maria Febi B. [1 ]
Soriano-Estrella, Agnes L. [1 ]
机构
[1] Univ Philippines, Philippine Gen Hosp, Dept Obstet & Gynecol, Manila, Philippines
关键词
choriocarcinoma; computed tomography; gestational trophoblastic diease; gestational trophoblastic neoplasia; hydatidiform mole; metastasis; micrometastasis; molar pregnancy; placentalsite trophoblastic tumor; trophoblastic tumor; DISEASE;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To determine the significance of pulmonary metastases diagnosed only by chest computed tomography (CT) on the clinical outcome of patients with low-risk gestational trophoblastic neoplasia (GTN). STUDY DESIGN: A retrospective cohort study which included low-risk GTN patients with normal baseline chest x-ray findings who underwent chest CT managed at the section of trophoblastic diseases in a tertiary government hospital. RESULTS: Following chest CT scan, 13 patients were proven to have pulmonary lesions, while 45 patients had normal chest CT scan. All 58 patients who underwent chest CT scan went into remission regardless of the presence or absence of pulmonary micrometastasis. Of those, 52 were able to have regular hCG monitoring 2 years after remission and were able to maintain normal hCG levels. However, it was noted that 5 out of the 13 patients with pulmonary micrometastasis had resistance after the first line of treatment, but eventually all went into remission after second line or salvage chemotherapy. CONCLUSION: The presence of pulmonary micrometastasis diagnosed only by chest CT does not seem to alter the clinical outcome among patients with low-risk GTN. Thus, a chest CT may not be necessary prior to starting single-agent chemotherapy in this group of patients.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条
  • [31] Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4)
    Jin, Tianzhe
    Zhou, Zijun
    Lin, Mengmeng
    Yuan, Shuo
    Xue, Yite
    Yin, Taotao
    Xu, Ruiyi
    Chen, Bingxin
    Zhang, Jianwei
    Sun, Jiehao
    Li, Xiao
    Hu, Yan
    Chen, Lili
    Wang, Hui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (03): : 1353 - 1362
  • [32] Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017
    Zhu, Chen-Chen
    Liu, Han-Yuan
    Wei, Ying
    Shen, Zhen
    Qian, Li-Li
    Song, Wei-Guo
    Wang, Juan
    Wu, Da-Bao
    Zhang, Xue-Fen
    Zhou, Ying
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (03): : 332 - 337
  • [33] First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive
    Bolze, Pierre-Adrien
    Mathe, Melodie
    Hajri, Touria
    You, Benoit
    Dabi, Yohann
    Schott, Anne-Marie
    Patrier, Sophie
    Massardier, Jerome
    Golfier, Francois
    GYNECOLOGIC ONCOLOGY, 2018, 150 (02) : 282 - 287
  • [34] Low-Risk Gestational Trophoblastic Neoplasia in Manitoba Experience With Alternating Methotrexate and Dactinomycin
    Carlson, Vanessa
    Walters, Leslea
    Lambert, Pascal
    Dean, Erin
    Lotocki, Robert
    Altman, Alon D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1448 - 1452
  • [35] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [36] Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
    Sheikhhasani, Shahrzad
    Abdolrazaghnejad, Aghdas
    Mousavi, Azam Sadat
    Akhavan, Setareh
    Zamani, Narges
    Feizabad, Elham
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 47 - 52
  • [37] Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
    Li, Kemin
    Zhang, Mengpei
    Yin, Rutie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
    Wu, Xiaodong
    Qin, Jiale
    Shen, Tao
    Fei, Weidong
    Chen, Lili
    Xie, Xing
    Lu, Weiguo
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (04) : 1 - 11
  • [39] Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone
    Couder, Florence
    Massardier, Jerome
    You, Benoit
    Abbas, Fatima
    Hajri, Touria
    Lotz, Jean-Pierre
    Schott, Anne-Marie
    Golfier, Francois
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (01) : 80.e1 - 80.e7
  • [40] Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia
    Maesta, Izildinha
    Growdon, Whitfield B.
    Goldstein, Donald P.
    Bernstein, Marilyn R.
    Horowitz, Neil S.
    Cunha Rudge, Marilza Vieira
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 312 - 316